Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115780) titled 'Long-term significant efficacy of gemcitabine combined with nedaplatin in persistent refractory nasopharyngeal carcinoma involving the cavernous sinus and distant metastasis:a case report' on Dec. 31, 2025.
Study Type: Observational study
Study Design:
Case study
Primary Sponsor: The First Affiliated Hospital of Army Medical University
Condition:
Nasopharyngeal carcinoma involving the cavernous sinus
Pulmonary metastasis of nasopharyngeal carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-31
Target Sample Size: Case report:1;
Countries of Recruitment:
China
To...